A U.S. government scientist who oversees the team responsible for collecting data on COVID-19 and RSV hospitalizations used ...

The 17 members of the CDC's vaccine advisory committee, who were ousted last week, argued their abrupt dismissal has "left ...

Kennedy last week announced he would “retire” the entire panel that guides U.S. vaccine policy. He also quietly removed Dr.

Fiona Havers, who oversaw CDC respiratory virus data, told colleagues she no longer had confidence the data would be used ...

A Seattle infectious disease doctor, whose work was pivotal early in the COVID pandemic, shares more on her experience with ...

The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the ...

Moderna's shares fell 2.5% before the bell on Friday, on concerns whether a new CDC advisory panel would back the use of the ...

Moderna's shares fell 2.3% on Friday on concerns about whether a new CDC advisory panel would back the use of the company's ...

In JAMA, the peer-reviewed medical journal, the ousted board members fired off against Kennedy’s cull. They wrote that the dismissals and the resulting replacement with MAHA minions, as well as the ...

A Centers for Disease Control and Prevention official who led the agency's network to study hospitalization trends from infectious diseases like COVID-19 has resigned in protest following Health and ...

The CDC currently recommends a single dose of the ... Morningstar's Anderson projects the total RSV vaccine market to be worth about $3.9 billion by 2030 globally, with Moderna gaining about ...